Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02201992 |
|---|---|
| Brief Title: | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) |
| First Submitted : | July 21, 2014 |
| First Submitted that Met QC Criteria : | July 24, 2014 |
| First Posted : | July 28, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 20, 2023 |
| Last Update Posted : | June 22, 2023 |